The consistency between TRIUMPH-4 and TRIUMPH-1 two different populations, different trial durations, nearly identical results is the strongest evidence yet that retatrutide's efficacy is reproducible
Semaglutide has been studied for GLP-1 receptor signaling, incretin biology, central appetite regulation, beta-cell preservation, cardiovascular inflammation, NASH/NAFLD resolution, and neurodegenerative disease
[1] [8] Phase 2 trial data published in the New England Journal of Medicine (Jastreboff et al., 2023) demonstrated substantial reductions in body weight with retatrutide, and Phase 3 trials are currently registered and under way (ClinicalTrials.gov)
Purchaser responsibility Purchasers must be 21 or older and are responsible for determining and complying with all institutional, local, provincial, and federal requirements that apply to their activities